Dashboard|IRON – Overview

IRON

Disc Medicine, Inc.

Healthcare • CIK: 0001816736

Market Cap

$2.80B

P/E (TTM)

-13.3x

Rev Growth (TTM)

—

Net Margin (TTM)

—

FCF Yield (TTM)

-6.5%

FCF Margin (TTM)

0.0%

LATEST EARNINGS

•

Q4 FY2025

•

8 days ago

•View source

Revenue

N/A

—

Net Income

N/A

—

EPS

N/A

—

•Strong cash position with approximately $791 million in cash, cash equivalents, and marketable securities as of December 31, 2025, providing runway into 2029.
•Initial data from Phase 2 study of DISC-0974 in patients with anemia of myelofibrosis (MF) presented at ASH conference demonstrated meaningful overall anemia responses.
•Progressing ongoing Phase 2 study of DISC-3405 in polycythemia vera (PV) and initiated a Phase 1b study of DISC-3405 in sickle cell disease (SCD) in Q4 2025.

View Full Earnings →

Cash Flow Health

Free Cash Flow0/8 positive

TTM$-181M

FCF Margin

TTM0.0%

Sector: 0.0%Below Avg

OCF Margin–

OCF/NI0.85x

CapEx Coverage-193.3x

FCF Yield-6.5%

FCF Growth (2Y)–

Cash Conversion Cycle

–

View Insights from Latest Filing →View Full Cash Flow Statement →

Capital Allocation & Returns

Total Shareholder Yield

TTM0.0%

Div Yield0.0%

Insufficient data

Dividend & Payout Metrics

Dividend Yield (TTM)0.0%

Free Cash Flow (TTM)$-181.3M

Capital Return / FCF0.0%

Est. Dividends Paid (TTM)$0

Shows how management rewards shareholders

Operational Efficiency & Returns

Return on Invested CapitalTTM

-37.0%

Moderate

-0.1% YoY-16.2%

P25MedianP75

25th pctl (med: 0.0%)

DuPont BreakdownROIC = Margin × Turn × (1+D/E)

NOPAT Margin

–

Asset Turnover

0.00x

8Q: 0.00x

Leverage (1+D/E)

1.00x

D/E: 0.00x

Asset & CapEx Efficiency

CapEx Intensity

0.1%

8Q:0.0%

CapEx/Depreciation

3.32x

Asset-based ROIC formula

Full Analysis

QUARTERLY TRENDS

No data available

Valuation Analysis

Fair Value

Price-to-EarningsTTM

-13.3x

Volatile

8Q: -48.8x+1416%

Multiple expansion without fundamental improvement

Valuation Lenses

Earnings

-13.3x

vs – sector

Cash Flow

-11.9x

EV/FCF vs –

Growth-Adj

–PEG

N/A

Quality-Adj

–P/E per %ROIC

ROIC: -37.0%

Shareholder Returns

Dividend

–

Buyback

–

Total Yield

–

Market Cap$2.80B

EV$2.15B

Multi-angle valuation analysis with sector context

Business Quality & Moat

Overall Quality Score

-36/100

Below Average

Composite score: Returns (40%) + Consistency (30%) + Earnings Quality (30%)

Returns on Capital

Return on Equity (ROE)Below Avg

-34.8%

8Q:–

Return on Invested Capital (ROIC)Below Avg

-37.0%

8Q:–

-16.2%

Earnings Quality

Cash Conversion

0.85x

OCF / Net Income

FCF Consistency

–

Positive quarters

Competitive Moat Indicators

Pricing Power

Gross Margin–

Capital Efficiency

Invested Capital Turnover–

Working Capital

Cash Conversion Cycle–

Growth Quality & Momentum

Growth Rates

Revenue Growth YoY

N/A

OpInc Growth YoY

N/A

EPS Growth YoY

-50.1%

FCF 3Y CAGR

N/A

Margin Quality & Sustainability

Moderate

Profitability Cascade

Gross

—

Operating

—

Net

—

Margins Unknown

Earnings Quality Signals

SBC / Revenue

—

FCF vs Net Gap

—

FCF: 0.0% | Net: —

Quality = stability + cash conversion + low dilution

Balance Sheet & Solvency

Fortress

Net Debt / EBITDA

Net Cash

(0.0x)Net Cash: $791.20M

Interest Coverage

–

+Net cash position: $791.20M

Leverage Metrics

Debt-to-Equity

0.00x

Balance sheet risk & solvency analysis